On Thursday, Shares of Northern Trust Corporation (NASDAQ:NTRS), gained 0.33% to $69.90.
In response to the increasing demand for Northern Trust’s (NTRS) securities lending and transition administration services it has declared a series of appointments within its global capital markets business.
Sunil Daswani has been designated to the newly created role as head of international securities lending across Europe, Middle East Africa (EMEA) and Asia-Pacific (APAC). Daswani joined Northern Trust in 2002 and has held a number of roles based in London and Hong Kong, most recently as head of client service and sales for Northern Trust’s Capital Markets group in EMEA and APAC.
In addition to his new responsibilities, Daswani maintains oversight of Northern Trust’s transition administration sales and relationship administration teams across EMEA and APAC.
Northern Trust Corporation, a financial holding company, provides asset servicing, fund administration, asset administration, fiduciary, and banking solutions for corporations, institutions, families, and individuals worldwide. It operates in two segments, Corporate & Institutional Services (C&IS) and Wealth Administration.
Shares of TerraForm Power Inc (NASDAQ:TERP), declined -4.18% to $20.40, during its last trading session.
SunEdison, declared a joint venture (JV) for the Three Cedars solar project, a 265 megawatt (MW) DC, or 210 MW AC, solar project in Utah, developed by SunEdison. The declarement marks the expansion of a joint venture recently declared regarding Dominion’s investment in the 420 MW DC Four Brothers solar project in Utah.
Similar to Four Brothers, the Three Cedars project is contracted under long-term power purchase agreements for 20 years with PacifiCorp (A-/A3), a partner of Berkshire Hathaway Energy. The project is now under construction and fully financed with an predictable commercial operation date of mid-2016.
SunEdison’s 50 percent interest in both the Four Brothers and Three Cedars projects are on the Call Right Projects List for TerraForm Power, Inc. (TERP), a global owner and operator of clean energy power plants.
TerraForm Power, Inc. owns and operates solar and wind generation assets serving utility, commercial, and residential customers. As of February 20, 2015, its portfolio compriseed of solar and wind projects located in the United States, Canada, the United Kingdom, and Chile with an aggregate nameplate capacity of 1,507.3 megawatt.
At the end of Thursday’s trade, Shares of RR Donnelley & Sons Co (NASDAQ:RRD), lost -1.61% to $15.30.
R.R. Donnelley & Sons Company, declared its participation at the CL King Best Ideas Conference in New York City on Thursday, September 10th with a presentation planned at 8:45am Eastern time.
R.R. Donnelley & Sons Company provides integrated communications solutions to private and public sector clients in the United States and internationally. The company operates through Publishing and Retail Services, Variable Print, Planned Services, and International segments.
Finally, AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), ended its last trade with -4.73% loss, and closed at $57.65.
AMAG Pharmaceuticals, declared that Joseph Vittiglio has joined the company as senior vice president, general counsel and secretary. In this position, Mr. Vittiglio will oversee all legal affairs of the company.
“We are happy to welcome Joe to the executive team at AMAG,” stated Frank Thomas, president and chief operating officer at AMAG. “Joe’s legal expertise in the pharmaceutical industry and transaction experience will be a tremendous asset to AMAG as we continue to aggressively pursue the acquisition of products and companies that leverage our current therapeutic areas expertise and our corporate and commercial infrastructure.”
AMAG Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that focuses on maternal health, anemia, and cancer supportive care. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women with a singleton pregnancy; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the administration of oral mucocitis/stomatiits and various types of oral wounds.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
